TriMark Publications, Nov 2011, Pages: 165
Biosciences Revenue Shares 163
INDEX OF TABLES
Table 2.1: MassSpectrometry Utilization in the Clinical and LifeScience Space 17
Table 2.2: MassSpectrometry Tests for Clinical Applications 20
Table 2
Frost & Sullivan, Feb 2008, Pages: 115
This Frost & Sullivan research service titled Opportunities for the European MassSpectrometry Markets in Clinical Applications provides an overview of the massspectrometry markets in Europe, along
BioInformatics, LLC, Oct 2010
of computational approaches to the analysis of membrane components have brought new life to membrane structural biology, creating opportunities for suppliers of membrane structural biology products.
Unique
Frost & Sullivan, July 2010, Pages: 83
This research service provides a strategic analysis of the National Institutes of Health (NIH) American Recovery and Reinvestment Act (ARRA) funding impact on the lifescience research tools
Yole Development, Jan 2006
and the business opportunities for semiconductor and MEMS companies. It also answers the question: "how could IC and MEMS companies become a key leader of the LifeSciences field?" A very futuristic approach of Life
Business Insights, April 2008, Pages: 265
and systems biology
Streamlining biomarker validation
Case studies
BG Medicine
Caprion Proteomics
Clinical Data
Compugen
Digilab Peptidomics
Metabolon
Monarch LifeSciences
Pronota
Source MDx
Markets and Markets, Sep 2009, Pages: 189
such as Biocon, Dr. Reddy’s Lab, Intas, LG LifeSciences, Ranbaxy, Reliance LifeSciences, Sandoz, Teva, and Wockhardt. Favorable regulatory developments in the biosimilars sector are expected to increase
John Wiley and Sons Ltd, March 2011, Pages: 636
Lifesciences have advanced at a rapid speed. The information of cell and molecular biology as well as genetics can be applied to biotechnology and medicine. This new field has been termed
Future Markets, Inc., Feb 2010, Pages: 196
themselves to capitalize on long-term technology growth opportunities in semiconductors, bio-medicine and lifesciences, LED and solar and nanotechnology.
A particular strategic focus of larger companies
Decision Resources, Inc., Dec 2006, Pages: 34
reaction (PCR), fluorescence in situ hybridization (FISH), and massspectrometry (MS) to evaluate maternal blood and urine samples. Which companies will have an impact on the market?
Scope
Invasive prenatal
Axis Research Mind, Nov 2011, Pages: 615
in. An in-depth analysis across the geographic regions provides strategic business intelligence for lifescience and as well as healthcare sector investments. The study offers profitable investment strategies for R
Axis Research Mind, Nov 2011, Pages: 615
in. An in-depth analysis across the geographic regions provides strategic business intelligence for lifescience and as well as healthcare sector investments.
The study offers profitable investment strategies
Frost & Sullivan, March 2004
solutions continues to provide fresh opportunities for new entrants, though many giants are present in this well-established market, she concludes.
1 WORLD LIFESCIENCEMASSSPECTROMETRY MARKETS
Overview
GlobalData, April 2011, Pages: 46
and massspectrometry technologies, and TA Instruments division that supports thermal analysis technologies. The company’s products are widely utilized by pharmaceutical, biochemical, lifesciences
